Le Lézard
Classified in: Health, Business
Subject: ACC

HealthpointCapital Announces $100 Million First Closing of Musculoskeletal Fund IV


NEW YORK, Oct. 9, 2018 /PRNewswire/ -- HealthpointCapital, the leading private equity firm focused exclusively on musculoskeletal healthcare, today announced the successful first closing at $100 Million of its fourth fund. The Musculoskeletal Fund IV will continue HealthpointCapital's successful strategy of investing in differentiated technology and service companies in the orthopedics, spine, dental, maxillofacial, rehabilitation and digital health sectors. The Fund's target size is $500 Million, with the intention to invest in eight to ten innovative growth-stage companies that can benefit from HealthpointCapital's sector focus, industry / management experience, and investment.

Commenting on the announcement, Mike Mogul, HealthpointCapital's President, said: "The first closing for Fund IV represents a milestone and a validation of our strategy. Musculoskeletal healthcare offers attractive opportunities that require not only capital, but also operational expertise and strong healthcare professional and commercial relationships."

"Healthcare is rapidly evolving, and we will continue to focus on innovation that addresses both patient outcomes and care costs," said John Foster, CEO and Founder of HealthpointCapital. "We are grateful for our investors' support and are actively sourcing new investments for the fund."

Notable recent exits for HealthpointCapital include Blue Belt Technologies, Inc. (acquired by Smith & Nephew plc) and BioHorizons, Inc. (acquired by Henry Schein, Inc.).

About HealthpointCapital

Founded in 2002, HealthpointCapital is the leading private equity firm focused exclusively on the musculoskeletal sector. The Firm is led by CEO and founder John H. Foster and Mike Mogul, former Group President, Orthopaedics at Stryker Corporation and former CEO of DJO Global. HealthpointCapital brings together extensive medical technology operating experience, strong private equity track record and a deep network of relationships to help portfolio companies accelerate growth.

For additional information, visit www.healthpointcapital.com.

For investor or media inquiries, please contact:
Tessa Cicitta, HealthpointCapital, 212-935-7780 or [email protected]

 

SOURCE HealthpointCapital


These press releases may also interest you

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

at 18:15
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...



News published on and distributed by: